Variant report

Variant	nsv971856
Chromosome Location	chr10:118626730-118630578
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr10:118629182..118631041-chr10:118634617..118636655,2	K562	blood:
2	chr10:118606549..118608975-chr10:118626771..118628550,2	MCF-7	breast:
3	chr10:118608746..118610922-chr10:118630498..118633228,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000188316	chromatin interactions
ENSG00000225302	chromatin interactions

Extended variants
information (count: 137 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:137 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs148252211	chr10:118626735-118626736	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs35500650	chr10:118626754-118626755	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs140365728	chr10:118626775-118626776	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs370927113	chr10:118626868-118626869	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs534650036	chr10:118626886-118626887	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs61872988	chr10:118626931-118626932	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs368485127	chr10:118626932-118626933	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs201224986	chr10:118626933-118626934	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs79586627	chr10:118626948-118626949	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs35426438	chr10:118626950-118626951	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs75572760	chr10:118626952-118626953	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs554830703	chr10:118626973-118626974	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs574766902	chr10:118627028-118627029	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs543380989	chr10:118627040-118627041	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs563461022	chr10:118627061-118627062	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs576888771	chr10:118627077-118627078	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs76904969	chr10:118627129-118627130	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs76662489	chr10:118627131-118627132	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs187196183	chr10:118627168-118627169	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs73387534	chr10:118627171-118627172	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs528677122	chr10:118627184-118627185	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs150383773	chr10:118627206-118627207	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs548637036	chr10:118627299-118627300	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs137902714	chr10:118627339-118627340	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs142396028	chr10:118627370-118627371	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs528991045	chr10:118627440-118627441	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs550717147	chr10:118627444-118627445	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs145942588	chr10:118627507-118627508	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs192167018	chr10:118627522-118627523	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs552239548	chr10:118627651-118627652	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs557479914	chr10:118627653-118627654	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs555564222	chr10:118627657-118627658	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs562563624	chr10:118627668-118627669	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs533180544	chr10:118627675-118627676	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs565769410	chr10:118627700-118627701	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs182629010	chr10:118627723-118627724	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs554586423	chr10:118627732-118627733	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs78299461	chr10:118627755-118627756	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs551691523	chr10:118627756-118627757	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs537059031	chr10:118627793-118627794	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs566818233	chr10:118627832-118627833	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs556892663	chr10:118627848-118627849	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs576825086	chr10:118627914-118627915	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs545934630	chr10:118627969-118627970	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs138557148	chr10:118627996-118627997	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs567791424	chr10:118628014-118628015	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs115088144	chr10:118628026-118628027	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs1637571	chr10:118628036-118628037	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
49	rs547024583	chr10:118628042-118628043	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs372074599	chr10:118628051-118628052	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Prostate cancer	18632612	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Lung cancer	18438408	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	20729466	CNVD
Paraganglioma	17535989	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Pulmonary chondroma	17535989	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	17387387	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	16608533	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cornelia de Lange syndrome	24599119	CNVD
T-cell lymphomas	19863542	CNVD
Breast cancer	16397240	CNVD
Urothelial carcinoma	21177765	CNVD
Chronic lymphocytic leukemia	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Hepatocellular carcinoma	16750200	CNVD
Barrett''s syndrome	19417022	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Neuroticism	17667963	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22522925	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:36 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:118617800-118626800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
2	chr10:118621800-118628800	Weak transcription	Brain Cingulate Gyrus	brain
3	chr10:118623600-118628800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
4	chr10:118626400-118627000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
5	chr10:118626600-118628200	Enhancers	NHEK	skin
6	chr10:118626800-118627000	Enhancers	Breast Myoepithelial Primary Cells	Breast
7	chr10:118627000-118628000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
8	chr10:118627000-118628000	Enhancers	Liver	Liver
9	chr10:118627000-118628000	Weak transcription	Fetal Brain Male	brain
10	chr10:118627000-118628200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
11	chr10:118627400-118627600	Enhancers	iPS-15b Cell Line	embryonic stem cell
12	chr10:118627800-118628000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
13	chr10:118627800-118628800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
14	chr10:118628000-118628200	Enhancers	Fetal Brain Male	brain
15	chr10:118628000-118629000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
16	chr10:118628000-118630200	Weak transcription	Liver	Liver
17	chr10:118628400-118631400	Weak transcription	Primary T killer memory cells from peripheral blood	blood
18	chr10:118628800-118629200	Enhancers	iPS-20b Cell Line	embryonic stem cell
19	chr10:118628800-118629400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
20	chr10:118628800-118629400	Enhancers	iPS-15b Cell Line	embryonic stem cell
21	chr10:118628800-118629600	Enhancers	HUES48 Cell Line	embryonic stem cell
22	chr10:118628800-118629600	Enhancers	iPS-18 Cell Line	embryonic stem cell
23	chr10:118629000-118629400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
24	chr10:118629000-118629600	Enhancers	HUES64 Cell Line	embryonic stem cell
25	chr10:118629200-118629600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
26	chr10:118629200-118632000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
27	chr10:118629400-118631800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
28	chr10:118629400-118632400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
29	chr10:118629600-118630000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr10:118629600-118632000	Weak transcription	HUES48 Cell Line	embryonic stem cell
31	chr10:118629600-118632200	Weak transcription	HUES64 Cell Line	embryonic stem cell
32	chr10:118629600-118632200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
33	chr10:118630000-118630800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
34	chr10:118630000-118630800	Enhancers	Fetal Intestine Large	intestine
35	chr10:118630200-118630400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
36	chr10:118630200-118630800	Enhancers	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links